Extraneal -Extraneal is indicated for a single daily exchange for the long (8-to 16- hour) dwell during continuous ambulatory peritoneal dialysis(CAPD) or automated peritoneal dialysis (APD) for the management of end-stage renal disease. Extraneal is also indicated to improve(compared to 4.25% dextrose) long-dwell ultrafiltration and clearance of creatinine and urea nitrogen in patients with high average or greater transport characteristics, as defined using the peritoneal equilibration test (PET). (See CLINICAL PHARMACOLOGY, Clinical Studies ) As a once-daily replacement for a single dextrose exchange as part of a CAPD or automated peritoneal dialysis (APD)regimen for the treatment of chronic renal failure, particularly for patients who have lost ultrafiltration on dextrose solutions, because it can extend time on CAPD therapy in such patients.
Indications: peritoneal dialysis
--------------------------------------------------
附件:
201412820341429.pdf